Compassionate use, named patienthttps://legemiddelverket.no/english/import-wholesaling-and-retailing/compassionate-use-named-patient-norwegian-godkjenningsfritakCompassionate use, named patientIn order to use medicines without Market Authorisation (MA) in Norway, prescribers have to apply for compassionate use, named patient (in Norwegian: Godkjenningsfritak).1720
Dispensing regulations (utleveringsbestemmelser)https://legemiddelverket.no/english/import-wholesaling-and-retailing/dispensing-regulations-utleveringsbestemmelserDispensing regulations (utleveringsbestemmelser)NOMA may determine that a drug will be subject to dispensing regulation (1). The pharmacy has a duty to ensure that the requirements for dispensing are met for these medicinal products (2).421NOMA may determine that a drug will be subject to dispensing regulation. The pharmacy has a duty to ensure that the requirements for dispensing are met for these medicinal products.
Import of medicinal products for clinical studies in Norwayhttps://legemiddelverket.no/english/import-wholesaling-and-retailing/import-of-medicinal-products-for-clinical-studies-in-norwayImport of medicinal products for clinical studies in NorwayGeneral guideline regarding persission to import medicinal products for clinical studies in Norway. The guideline also covers the permission to export such products.1498
Importing medicines for personal usehttps://legemiddelverket.no/english/import-wholesaling-and-retailing/importing-medicines-for-personal-useImporting medicines for personal useDifferent rules regarding import of medicines for personal use in the form of consignments and import of medicines when bringing them with you.1616
Procedure for release of blood products and vaccines to the Norwegian markethttps://legemiddelverket.no/english/import-wholesaling-and-retailing/procedure-for-release-of-blood-products-and-vaccines-to-the-norwegian-marketProcedure for release of blood products and vaccines to the Norwegian marketThe Norwegian Medicines Agency follows the EC administrative procedure for Official control authority batch release. 422
Wholesaling in Norway for the products and facilities covered by the MIAhttps://legemiddelverket.no/english/import-wholesaling-and-retailing/wholesaling-in-norway-for-the-products-and-facilities-covered-by-the-miaWholesaling in Norway for the products and facilities covered by the MIAHolders of a Manufactoring and Importation Authorisation (MIA) issued within EU/EEA can perform wholesaling in Norway for the products and facilities covered by the MIA. NoMA should be notified when planning to perform such activities in Norway.1099

​Fant du det du lette etter?